CVE:VM - Voyageur Pharmaceuticals Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: C$0.55
  • Forecasted Upside: 450.00 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
C$0.10
▼ -0.005 (-4.76%)

This chart shows the closing price for VM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Voyageur Pharmaceuticals Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VM

Analyst Price Target is C$0.55
▲ +450.00% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Voyageur Pharmaceuticals in the last 3 months. The average price target is C$0.55, with a high forecast of C$0.00 and a low forecast of C$0.00. The average price target represents a 450.00% upside from the last price of C$0.10.

This chart shows the closing price for VM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Voyageur Pharmaceuticals.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/22/2022Fundamental ResearchBoost Price TargetBuyC$0.39 ➝ C$0.55
6/16/2020Fundamental ResearchSet Price TargetBuyC$0.39
1/21/2020Fundamental ResearchSet Price TargetBuyC$0.39
1/7/2020Fundamental ResearchInitiated CoverageBuyC$0.39
(Data available from 7/5/2017 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/6/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/5/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/4/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/6/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/5/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/5/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/4/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/4/2022

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.
Read More

Today's Range

Now: C$0.10
Low: C$0.10
High: C$0.10

50 Day Range

MA: C$0.11
Low: C$0.10
High: C$0.12

52 Week Range

Now: C$0.10
Low: C$0.08
High: C$0.20

Volume

18,000 shs

Average Volume

135,883 shs

Market Capitalization

C$11.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Voyageur Pharmaceuticals?

The following sell-side analysts have issued stock ratings on Voyageur Pharmaceuticals in the last twelve months: Fundamental Research.
View the latest analyst ratings for VM.

What is the current price target for Voyageur Pharmaceuticals?

0 Wall Street analysts have set twelve-month price targets for Voyageur Pharmaceuticals in the last year. Their average twelve-month price target is C$0.55, suggesting a possible upside of 450.0%.
View the latest price targets for VM.

What is the current consensus analyst rating for Voyageur Pharmaceuticals?

Voyageur Pharmaceuticals currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VM will outperform the market and that investors should add to their positions of Voyageur Pharmaceuticals.
View the latest ratings for VM.

How do I contact Voyageur Pharmaceuticals' investor relations team?

The company's listed phone number is 587-779-6166. The official website for Voyageur Pharmaceuticals is www.voyageurminerals.ca. Learn More about contacing Voyageur Pharmaceuticals investor relations.